Clinical Trials Verified stories whose regulatory record supports clinical-trial access. Eligibility and enrollment are never guaranteed.
Filter clinical trials Filters Results 97 verified trial-access stories match your filters.
Important: Eligibility and enrollment are not guaranteed, and listing here is not a treatment recommendation. Talk to your care team.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Breast Cancer
Trial identifier NCT06429761
Trial phase Phase 4 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with BREAST CANCER who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-11 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-11 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT06687369
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Non Squamous Non Small Cell Lung Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-10 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-10 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Endometrial (Uterine) Cancer
Trial identifier NCT07166094
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Endometrial Cancer, Recurrent or Progressive Endometrial Cancer who meet the study-specific registry eligibility criteria; sex eligibility: female.
Last reviewed 2026-09-09 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-09 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT06345729
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Non-small Cell Lung Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-08 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-08 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Bladder Cancer
Trial identifier NCT04628767
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Renal Pelvis and Ureter Urothelial Carcinoma who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-03 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-03 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Stomach (Gastric) Cancer
Trial identifier NCT06203600
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8 who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-03 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-03 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lymphoma
Trial identifier NCT06084936
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Lymphoma who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-03 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-03 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Breast Cancer
Trial identifier NCT06790693
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Breast Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-03 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-03 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Pancreatic Cancer
Trial identifier NCT04340141
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Pancreatic Adenosquamous Carcinoma, Resectable Pancreatic Adenocarcinoma, Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8 who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-02 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-02 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Endometrial (Uterine) Cancer
Trial identifier NCT06340568
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Endometrial Cancer who meet the study-specific registry eligibility criteria; sex eligibility: female.
Last reviewed 2026-09-01 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-01 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
CancerDiscoveries summarizes verified records in its database. Absence of a listing here does not establish that a treatment lacks regulatory authorization or access.